ACE inhibitors: all 391 studies that test it
Page 4 of 4. Open to participants first (24), then studies with results posted, then the rest; newest registration first within each.
- Moexipril for Primary Biliary CirrhosisCompletedNCT00588302Phase 2
- Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3Status unknownNCT00565396Not applicable
- Study to Examine the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination of COREG CR and Lisinopril.CompletedNCT00557128Phase 1
- Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA NephropathyCompletedNCT00554502Phase 3
- A Study Investigating the Bioequivalence of the Fixed Dose Combination of COREG CR to COREG CR and ZESTRIL.CompletedNCT00552708Phase 1
- Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.CompletedNCT00549510Phase 1
- Effect of Enalapril Plus Folic Acid on Blood Pressure and GlycometabolismCompletedNCT00520247Phase 2
- Left Atrial Remodelling in Hypertension: Effects of Ramipril or IrbesartanStatus unknownNCT00517322Phase 4
- Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation StudyCompletedNCT00512759Phase 4
- Evaluation of Potential for Orthostatic Hypotension in Elderly HypertensivesCompletedNCT00508365Phase 1
- Preventing Microalbuminuria in Type 2 DiabetesCompletedNCT00503152Phase 3
- Preventing ESRD in Overt Nephropathy of Type 2 DiabetesCompletedNCT00494715Phase 3
- To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT PatientsCompletedNCT00489229Phase 3
- Angiotensin Converting Enzyme Inhibitors in Marfan SyndromeCompletedNCT00485368Phase 3
- Chicken-Diet vs. Enalapril to Reduce AlbuminuriaCompletedNCT00484068Not applicable
- Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential HypertensionCompletedNCT00473174Phase 4
- Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential HypertensionCompletedNCT00461903Phase 3
- Prevention of Diabetes and HypertensionTerminatedNCT00456963Phase 4
- Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) InhibitorCompletedNCT00437463Phase 3
- Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes MellitusCompletedNCT00419835Phase 4
- Evaluation of Myocardial Improvement in Patients Supported by Ventricular Assist Device Under Optimal Pharmacological TherapyTerminatedNCT00402376Phase 4
- Sirolimus Therapy for Poor Prognosis Immunoglobulin A NephropathyCompletedNCT00396721Phase 2
- Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes MellitusCompletedNCT00367978Phase 4
- Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential HypertensionCompletedNCT00367094Phase 3
- Safety and Efficacy of Ramipril in the Treatment of Essential HypertensionStatus unknownNCT00366119Phase 4
- Safety and Effects of Ramipril Combined With CandesartanCompletedNCT00356395Phase 4
- Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential HypertensionCompletedNCT00355589Phase 3
- Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal InsufficiencyTerminatedNCT00338091Not applicable
- The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 DiabetesCompletedNCT00337298Not applicable
- Ramipril - HypertensionCompletedNCT00325806Phase 4
- Eplerenone, ACE Inhibition and AlbuminuriaCompletedNCT00315016Phase 2
- High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive PatientsTerminatedNCT00313547Phase 4
- Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic NephropathyCompletedNCT00311870Phase 4
- Effects of Sodium Intake on (PK/PD) Relationship of a Single Dose of a Renin Angiotensin System-BlockerCompletedNCT00310778Phase 1
- Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport SyndromeCompletedNCT00309257Phase 2
- Comparison of the Antihypertensive Efficacy of Valsartan and Enalapril After Missing One DoseCompletedNCT00302705Phase 4
- Prevention of Chemotherapy-induced Cardiotoxicity in High-risk PatientsCompletedNCT00292526Phase 4
- Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of HypertensionCompletedNCT00281593Phase 3
- Renal Protective Effect of ACEI and ARB in Primary HyperoxaluriaWithdrawnNCT00280215Phase 3
- Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPMCompletedNCT00274612Phase 4
- PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTNCompletedNCT00274599Phase 4
- DETAIL Study: Diabetes Exposed to Telmisartan and EnalaprilCompletedNCT00274118Phase 3
- Ramipril in Rheumatoid ArthritisCompletedNCT00273533Phase 2/3
- Benazepril for Advanced Chronic Renal InsufficiencyTerminatedNCT00270426Not applicable
- Management With Accupril Post Bypass GraftCompletedNCT00269243Phase 4
- FOCUS:Focus On Coronary Unstable SyndromesCompletedNCT00268619Phase 3
- Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)CompletedNCT00263393Phase 4
- Acute Haemodynamic Effects of Treatment With Angiotensin Converting Enzyme (ACE)-Inhibitors in Patients With Symptomatic Aortic StenosisStatus unknownNCT00252317Phase 4
- Comparison Of Morning And Evening Dosing Of Valsartan And Lisinopril In Patients With DiabetesCompletedNCT00241124Phase 4
- Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 DiabetesCompletedNCT00240422Phase 4
- Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney DiseaseStatus unknownNCT00235287Phase 4
- A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)CompletedNCT00235014Phase 4
- Russian Study of the Efficacy and Safety of Tarka in Patients With HypertensionCompletedNCT00235001Phase 4
- Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)CompletedNCT00234871Phase 4
- Tarka vs. Hyzaar in Patients With Metabolic Syndrome (STAR)CompletedNCT00234858Phase 4
- Canadian Study of Trandolapril on Blood Pressure in Hypertensive Patients (TRAIL)CompletedNCT00233532Phase 4
- Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric PatientsCompletedNCT00221845Phase 3
- Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and DiabetesTerminatedNCT00208221Phase 3
- S90652 in Paediatric HypertensionCompletedNCT00202592Phase 2
- S90652 in Paediatric HypertensionCompletedNCT00202553Phase 2
- Antialbuminuric Effects of Valsartan and LisinoprilTerminatedNCT00171600Phase 4
- Antiproteinuric Effect of Valsartan and LisinoprilCompletedNCT00171574Phase 4
- A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.CompletedNCT00171366Phase 3
- VALERIA: Valsartan in Combination With Lisinopril in Hypertensive Patients With MicroalbuminuriaCompletedNCT00171067Phase 3
- The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial DiseaseCompletedNCT00168467Phase 4
- Kallikrein-kinin (KKS) and Renin-angiotensin-aldosterone System (RAAS) in Primary AldosteronismCompletedNCT00155064Phase 4
- Cognitive/Cerebrovascular Consequences of HTN TreatmentCompletedNCT00151138Not applicable
- QWISE - Study of Quinapril in Women With Chest Pain, Coronary Flow Reserve Limitations and Evidence of Myocardial IschemiaCompletedNCT00150826Phase 4
- Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive WomenCompletedNCT00147524Phase 4
- The Study of Atherosclerosis With Ramipril and RosiglitazoneCompletedNCT00140647Phase 3
- Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk HypertensionCompletedNCT00139555Phase 4
- Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes MellitusCompletedNCT00136773Phase 4
- INVEST: INternational VErapamil SR Trandolapril STudyCompletedNCT00133692Phase 4
- IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering DrugsCompletedNCT00128518Phase 4
- Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive DeclineCompletedNCT00126516Phase 4
- Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney DiseaseCompletedNCT00118976Not applicable
- Angiotensin Converting Enzyme Inhibition in Children With Mitral RegurgitationTerminatedNCT00113698Phase 3
- The DREAM (Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication) TrialCompletedNCT00095654Phase 3
- Irbesartan Versus Placebo in Combination With Ramipril for Treatment of AlbuminuriaCompletedNCT00095290Phase 4
- In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic CancerCompletedNCT00086723Phase 1/2
- ACE Inhibition and Novel Cardiovascular Risk FactorsCompletedNCT00051389Phase 2
- Treatment of Pediatric Hypertension With Altace TrialCompletedNCT00044265Phase 4
- Pilot Study of Enalapril and Renal Function in Patients With IgA NephropathyCompletedNCT00006137Not applicable
- Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel InflammationCompletedNCT00005928Phase 2
- Phase II Study of the Pathophysiology and Treatment With Enalapril and Polystyrene Sulfonate for Pseudohypoaldosteronism, Type ICompletedNCT00004328Phase 2
- Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 DiabetesCompletedNCT00004266Phase 3
- Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell TransplantationCompletedNCT00004230Phase 3
- Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood CancerCompletedNCT00003070Phase 3
- Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)CompletedNCT00000558Phase 3
- Enalapril After Anthracycline CardiotoxicityCompletedNCT00000547Phase 3
- Studies of Left Ventricular Dysfunction (SOLVD)CompletedNCT00000516Phase 3